Pamela Ann Connealy

CIK 1796310 · CFO & COO · last filed 2025-08-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.67M

Companies

4

Total Filings

26

Lifetime Open-Market Net

$229.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OBIO Director 48,711 $4.10 $199.7K $0 8 2025-08-08
PYXS CFO & COO 2,226,036 $1.76 $3.92M $229.9K 15 2025-04-02
IMVT Chief Financial Officer 46,200 $33.62 $1.55M $0 1 2021-03-23
Immunovant, Inc. (IMVTW) Delisted Chief Financial Officer $0 2 2020-05-18

Recent Filings · Page 2 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-09-25 PYXS Buy (P) +12,000 $20.0K EDGAR
2023-09-22 PYXS Buy (P) +5,000 $8.7K EDGAR
2023-09-08 PYXS Grant (A) +187,793 $0 EDGAR
2023-07-24 OBIO Grant (A) +11,667 $0 EDGAR
2023-05-19 OBIO Grant (A) $0 EDGAR
2023-05-05 OBIO Exer (M) +758 $0 EDGAR
2023-05-05 OBIO Grant (A) $0 EDGAR
2023-03-28 PYXS Mixed +209,803 $0 EDGAR
2023-01-30 OBIO Grant (A) +3,488 $0 EDGAR
2023-01-03 PYXS Grant (A) +43,493 $0 EDGAR
Showing 1120 of 26
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.